Eiger BioPharmaceuticals Competitors and Similar CompaniesClear all

Eiger BioPharmaceuticals's competitors and similar companies include Cipla, Cadila Pharmaceuticals, CSL Behring and Mankind Pharma.

	Eiger BioPharmaceuticals Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.	CSL Behring CSL Behring is a provider of life-saving medicines.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2008	Founding Date 1935	Founding Date 1951	Founding Date 1904	Founding Date 1995
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Palo Alto, US HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations New Delhi, IN HQ
Employees	Employees 2433% increase	Employees 27,764	Employees 8,5201% increase	Employees 7,5692% decrease	Employees 16,2532% increase
Financial
Revenue (est.)	Revenue (est.) $15.8m (FY, 2023)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A
Cost of goods	Cost of goods $24k (FY, 2023)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit N/A	Gross profit $4.5b (FY, 2020)	Gross profit N/A
Net income	Net income ($75m) (FY, 2023)	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 88m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 239m